Syngen Biotech Market Cap

Syngen Biotech has a market cap or net worth of 3.85 billion as of May 13, 2025. Its market cap has decreased by -5.96% in one year.

Market Cap

3.85B

Enterprise Value

3.81B

Revenue

2.03B

Ranking

n/a

PE Ratio

15.94

Stock Price

142.00

Market Cap Chart

Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.85B, an increase of 934.49%. That is a compound annual growth rate of 12.05%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	3.85B	11.81%
Dec 30, 2024	3.44B	-16.45%
Dec 29, 2023	4.12B	-6.17%
Dec 30, 2022	4.39B	43.36%
Dec 30, 2021	3.06B	4.63%
Dec 31, 2020	2.93B	-8.09%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	171.52B
Caliway Biopharmaceuticals	110.55B
Bora Pharmaceuticals Co., LTD.	74.21B
Lotus Pharmaceutical	60.56B
Polaris Group	33.16B
Oneness Biotech	28.27B
Pegavision	27.14B
Lumosa Therapeutics	26.85B

Market Cap Rankings